Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Abstract

For patients receiving VEGF-TKI or ICI therapy, distinct plasma cytokines were associated with clinical benefit. Our findings support additional investigation into plasma cytokines as biomarkers in metastatic RCC.